Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease
Transplantation of stem cells for the treatment of Huntington’s disease (HD) garnered much attention prior to the turn of the century. Several studies using mesenchymal stem cells (MSCs) have indicated that these cells have enormous therapeutic potential in HD and other disorders. Advantages of usin...
Main Authors: | Andrew T. Crane, Julien Rossignol, Gary L. Dunbar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-03-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3425/4/1/202 |
Similar Items
-
Clinical trial perspective for adult and juvenile Huntington′s disease using genetically-engineered mesenchymal stem cells
by: Peter Deng, et al.
Published: (2016-01-01) -
Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases
by: Robert D. Wyse, et al.
Published: (2014-01-01) -
Role of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative Diseases
by: Bhairavi Srinageshwar, et al.
Published: (2016-02-01) -
ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation
by: Tina Zimmermann, et al.
Published: (2016-10-01) -
A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington’s Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities
by: Tuyana Malankhanova, et al.
Published: (2020-11-01)